← Evidence library

BIB_195

NICE TA766 — Pembrolizumab for adjuvant treatment of completely resected stage III melanoma. 2022. NHS England standard adjuvant route. [Tasks: 19a, 18] Tier: 2 Grade: N/A Retrieved: 2026-05-07

Evidence grade

N/A

Tier

2

Cited by tasks

19a, 18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_195/findings.md (research corpus). This page is a short context summary — not individualised medical advice.